ATE433992T1 - An menschlichen faktor-viii bindende moleküle und faktor-viii-ähnliche proteine - Google Patents

An menschlichen faktor-viii bindende moleküle und faktor-viii-ähnliche proteine

Info

Publication number
ATE433992T1
ATE433992T1 AT06009040T AT06009040T ATE433992T1 AT E433992 T1 ATE433992 T1 AT E433992T1 AT 06009040 T AT06009040 T AT 06009040T AT 06009040 T AT06009040 T AT 06009040T AT E433992 T1 ATE433992 T1 AT E433992T1
Authority
AT
Austria
Prior art keywords
factor viii
proteins
binding molecules
human factor
human
Prior art date
Application number
AT06009040T
Other languages
English (en)
Inventor
Jinan Yu
Daniel M Potter
Brian D Kelley
Jeffrey S Deetz
James E Booth
Original Assignee
Dyax Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dyax Corp filed Critical Dyax Corp
Application granted granted Critical
Publication of ATE433992T1 publication Critical patent/ATE433992T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Reciprocating Pumps (AREA)
AT06009040T 1999-01-04 2000-01-03 An menschlichen faktor-viii bindende moleküle und faktor-viii-ähnliche proteine ATE433992T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/224,785 US6197526B1 (en) 1999-01-04 1999-01-04 Polypeptides for binding human factor VIII and fragments of human factor VIII

Publications (1)

Publication Number Publication Date
ATE433992T1 true ATE433992T1 (de) 2009-07-15

Family

ID=22842198

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06009040T ATE433992T1 (de) 1999-01-04 2000-01-03 An menschlichen faktor-viii bindende moleküle und faktor-viii-ähnliche proteine

Country Status (12)

Country Link
US (2) US6197526B1 (de)
EP (5) EP2301953B1 (de)
JP (3) JP4733272B2 (de)
AT (1) ATE433992T1 (de)
AU (3) AU769745B2 (de)
CA (1) CA2354599C (de)
DE (1) DE60042430D1 (de)
DK (4) DK2301953T3 (de)
ES (4) ES2499040T3 (de)
HK (1) HK1038756A1 (de)
PT (3) PT1705183E (de)
WO (1) WO2000040602A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7820796B2 (en) * 1998-03-12 2010-10-26 Genetics Institute, Llc. Methods for producing Factor VIII proteins
US6197526B1 (en) * 1999-01-04 2001-03-06 Dyax Corp. Polypeptides for binding human factor VIII and fragments of human factor VIII
US7112438B2 (en) * 1999-01-04 2006-09-26 Dyax Corp. Binding molecules for human factor VIII and factor VIII-like proteins
FR2830865B1 (fr) * 2001-10-17 2004-10-22 Centre Nat Rech Scient Leurres peptidiques pour la preparation de medicaments destines a la prevention ou au traitement des pathologies auto-immunes, ou des troubles lies a l'apparition d'anticorps diriges contre des proteines exogenes
US20030149246A1 (en) * 2002-02-01 2003-08-07 Russell John C. Macromolecular conjugates and processes for preparing the same
AU2003230509B2 (en) * 2002-04-29 2009-03-12 Affibody Ab Sandwich assay and kit
WO2007065691A2 (en) * 2005-12-07 2007-06-14 Technische Universität München Small peptidic and peptido-mimetic affinity ligands for factor viii and factor viii-like proteins
TW200745163A (en) * 2006-02-17 2007-12-16 Syntonix Pharmaceuticals Inc Peptides that block the binding of IgG to FcRn
US20110005918A1 (en) * 2007-04-04 2011-01-13 Akeson Mark A Compositions, devices, systems, and methods for using a nanopore
AU2008284047A1 (en) 2007-08-09 2009-02-12 Syntonix Pharmaceuticals, Inc. Immunomodulatory peptides
TWI573806B (zh) 2008-04-17 2017-03-11 巴克斯歐塔公司 生物活性胜肽
WO2010014909A1 (en) * 2008-08-01 2010-02-04 Syntonix Pharmaceuticals, Inc. Immunomodulatory peptides
US8324914B2 (en) 2010-02-08 2012-12-04 Genia Technologies, Inc. Systems and methods for characterizing a molecule
AU2011343813B2 (en) 2010-12-15 2015-05-21 Takeda Pharmaceutical Company Limited Eluate collection using conductivity gradient
HUE043894T2 (hu) * 2011-06-10 2019-09-30 Bioverativ Therapeutics Inc Koagulációt elõsegítõ vegyületek és alkalmazásuk módszerei
BR112016011195A2 (pt) 2013-11-18 2017-09-19 Rubius Therapeutics Inc Células eritroides enucleadas e seus métodos de fabricação, composição farmacêutica e seu uso, uso de uma população de células eritroides, biorreator, mistura de células e dispositivo médico
CN116731197A (zh) 2016-09-19 2023-09-12 豪夫迈·罗氏有限公司 基于补体因子的亲和层析
PL3661636T3 (pl) 2017-08-04 2024-03-18 Takeda Pharmaceutical Company Limited Aparatura i sposoby do sprzęgania przeciwciał z żywicą

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4757006A (en) 1983-10-28 1988-07-12 Genetics Institute, Inc. Human factor VIII:C gene and recombinant methods for production
SE8501050D0 (sv) 1985-03-05 1985-03-05 Kabivitrum Ab Biologically active fragments of human antihemophilic factor and method for preparation thereof
DE3683980D1 (de) 1985-04-12 1992-04-02 Genetics Inst Neue prokoagulierungsproteine.
EP0436597B1 (de) * 1988-09-02 1997-04-02 Protein Engineering Corporation Herstellung und auswahl von rekombinantproteinen mit verschiedenen bindestellen
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5661008A (en) 1991-03-15 1997-08-26 Kabi Pharmacia Ab Recombinant human factor VIII derivatives
SE468050C (sv) * 1991-03-15 1998-04-27 Pharmacia & Upjohn Ab Rekombinant derivat av human faktor VIII
AU1757592A (en) * 1991-03-27 1992-11-02 Scripps Research Institute, The Therapeutic fragments of von willebrand factor
ATE278958T1 (de) * 1996-03-20 2004-10-15 Dyax Corp Reinigung des gewebe plasminogenaktivators (tpa)
EP0954531A1 (de) 1996-06-06 1999-11-10 Lajolla Pharmaceutical Company Apl-immunreaktive peptide, deren konjugate und verfahren zur behandlung von apl-antikörpern vermittelten krankheiten
US5817752A (en) 1996-06-06 1998-10-06 La Jolla Pharmaceutical Company Cyclic polypeptides comprising a thioether linkage and methods for their preparation
JP2002514422A (ja) * 1998-05-08 2002-05-21 ステイヒテイング・サンキン・ブロードボールジーニング インヒビターを有する血友病ａ患者の診断および治療方法
US5994310A (en) 1998-09-03 1999-11-30 Bayer Corporation Peptide ligands for affinity purification of human Factor VIII
US6197526B1 (en) * 1999-01-04 2001-03-06 Dyax Corp. Polypeptides for binding human factor VIII and fragments of human factor VIII

Also Published As

Publication number Publication date
ES2524965T3 (es) 2014-12-16
AU2004201810A1 (en) 2004-05-27
CA2354599A1 (en) 2000-07-13
ES2390360T3 (es) 2012-11-12
AU2004201830B2 (en) 2007-04-05
EP2090582A2 (de) 2009-08-19
US6197526B1 (en) 2001-03-06
DK2298791T3 (en) 2014-12-08
DE60042430D1 (de) 2009-07-30
EP1705183A1 (de) 2006-09-27
WO2000040602A1 (en) 2000-07-13
JP2002536297A (ja) 2002-10-29
EP2298791A1 (de) 2011-03-23
EP2301953B1 (de) 2014-07-30
EP1705183B1 (de) 2009-06-17
JP5368371B2 (ja) 2013-12-18
EP2090582A3 (de) 2009-11-11
HK1155182A1 (en) 2012-05-11
US20010014456A1 (en) 2001-08-16
US6492105B2 (en) 2002-12-10
DK2090582T3 (da) 2012-10-15
JP2010254694A (ja) 2010-11-11
EP1147128A4 (de) 2004-10-13
AU769745B2 (en) 2004-02-05
EP1147128A1 (de) 2001-10-24
EP2298791B1 (de) 2014-11-12
HK1038756A1 (zh) 2002-03-28
HK1131398A1 (en) 2010-01-22
AU2004201830A1 (en) 2004-05-27
EP2301953A1 (de) 2011-03-30
EP2298791B8 (de) 2014-12-24
PT2298791E (pt) 2014-12-16
PT1705183E (pt) 2009-07-31
JP4733272B2 (ja) 2011-07-27
PT2301953E (pt) 2014-09-15
EP2090582B1 (de) 2012-09-19
CA2354599C (en) 2013-03-12
ES2328722T3 (es) 2009-11-17
ES2499040T3 (es) 2014-09-26
JP2013079272A (ja) 2013-05-02
AU2598200A (en) 2000-07-24
HK1155756A1 (en) 2012-05-25
DK2301953T3 (da) 2014-09-22
JP5572207B2 (ja) 2014-08-13
DK1705183T3 (da) 2009-10-19

Similar Documents

Publication Publication Date Title
ATE433992T1 (de) An menschlichen faktor-viii bindende moleküle und faktor-viii-ähnliche proteine
EP2270040A3 (de) Polypeptide zur Bindung an das B-Lymphozyten-stimulatorische Protein (BLyS)
WO2001004265A3 (en) C-terminal protein tagging
ITTO950367A0 (it) Proteine di prrsv ricombinanti, corredi diagnostici e vaccini contenenti tali proteine di prrsv ricombinanti.
WO2001053354A3 (en) Methods for treating tumors using a fusion protein comprising il-2- polypeptides and p185-specific binding molecules
IL153052A0 (en) Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
EP1623227A4 (de) Proteine, sensoren und verfahren zur charakterisierung von analyten damit
WO2005047459A3 (en) Sars nucleic acids, proteins, antibodies, and uses thereof
ATE221663T1 (de) Prionbindende proteine und deren verwendungen
EP1243923A4 (de) VERFAHREN ZUM AUFFINDEN EINES HEILMITTELS FÜR KREBS MIT HILFE VON INTERAKTIONSDOMÄNEN VON p53 UND MORTALIN
IL147527A0 (en) Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes
WO2001029220A3 (en) Mage-a12 antigenic peptides and uses thereof
AU2001240662A1 (en) Method for the esr-spectroscopic detection of changes in the transport properties of albumin in an albumin-containing sample, esr-spectrometer for carrying out said method, and use of the method for diagnostic purposes and for controlling albumin-containing preparations
WO2000057188A3 (fr) Proteines associees a un cancer mammaire et procede de detection de ces proteines
WO2001021794A3 (en) Smad associating polypeptides
EP1186662A3 (de) Prionbindendes Proteine und deren Verwendungen
WO2003044160A3 (en) Novel molecules of the card related protein family and uses thereof

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1705183

Country of ref document: EP

UEP Publication of translation of european patent specification

Ref document number: 1705183

Country of ref document: EP